Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck

被引:27
作者
Gavilanes, J
Moro, MA
Lizasoain, I
Lorenzo, P
Pérez, A
Leza, JC
Alvarez-Vicent, JJ
机构
[1] Hosp 12 Octubre, Dept Surg, Div Otolaryngol Head & Neck Surg, E-28041 Madrid, Spain
[2] Hosp 12 Octubre, Dept Pathol, E-28041 Madrid, Spain
[3] Univ Complutense Madrid, Dept Pharmacol, Madrid, Spain
关键词
D O I
10.1097/00005537-199901000-00028
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: To test whether nitric oxide synthase (NOS) is expressed in primary otolaryngologic tumors and whether this expression is associated with the degree of malignancy. Study Design: Twenty-six samples from the primary localization of human pharyngolaryngeal squamous cell carcinoma. Materials and Methods: the activity of calcium-dependent and calcium-independent NOS was analyzed by the conversion of L-[14C]-arginine into L-[14C]-citrulline. Results: NOS activity is below detectable levels in pharyngolaryngeal mucosa from noncancer patients. In the primary localization of the tumor, calcium-independent NOS activity is maximal at early stages of tumor growth, whereas calcium-dependent activity increases from early to advanced stages. Conclusions: These data suggest that tumor growth and malignancy is associated with a change in the enzymatic source of NO from calcium-independent NOS to calcium-dependent NOS isoform in primary localization, These data suggest that the inhibition of calcium-independent NOS activity in early stages and/or inhibition of calcium-dependent NOS activity in later stages could delay growth of solid tumors.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 20 条
[1]  
BEARHS OH, 1988, AM JOINT COMMITTEE C, P6
[2]   Role of nitric oxide in cell-mediated tumor cytotoxicity [J].
Cifone, MG ;
Cironi, L ;
Meccia, MA ;
Roncaioli, P ;
Festuccia, C ;
DeNuntiis, G ;
DAlo, S ;
Santoni, A .
ADVANCES IN NEUROIMMUNOLOGY, 1995, 5 (04) :443-461
[3]  
CRISSMAN JD, 1984, CANCER-AM CANCER SOC, V54, P2995, DOI 10.1002/1097-0142(19841215)54:12<2995::AID-CNCR2820541230>3.0.CO
[4]  
2-R
[5]  
Doi K, 1996, CANCER-AM CANCER SOC, V77, P1598, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1598::AID-CNCR27>3.0.CO
[6]  
2-U
[7]   NITRIC-OXIDE IS AN IMPORTANT MEDIATOR FOR TUMORICIDAL ACTIVITY IN-VIVO [J].
FARIASEISNER, R ;
SHERMAN, MP ;
AEBERHARD, E ;
CHAUDHURI, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9407-9411
[8]  
Fukumura D, 1997, AM J PATHOL, V150, P713
[9]   ROLES OF NITRIC-OXIDE IN TUMOR-GROWTH [J].
JENKINS, DC ;
CHARLES, IG ;
THOMSEN, LL ;
MOSS, DW ;
HOLMES, LS ;
BAYLIS, SA ;
RHODES, P ;
WESTMORE, K ;
EMSON, PC ;
MONCADA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4392-4396
[10]   PRODUCTION OF ANGIOGENIC ACTIVITY BY HUMAN MONOCYTES REQUIRES AN L-ARGININE NITRIC-OXIDE SYNTHASE-DEPENDENT EFFECTOR MECHANISM [J].
LEIBOVICH, SJ ;
POLVERINI, PJ ;
FONG, TW ;
HARLOW, LA ;
KOCH, AE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4190-4194